Pulmonary pressure-flow responses to exercise in heart failure treated with angiotensin receptor neprilysin inhibitor-Reference-Cited by-同舟云学术

Pulmonary pressure-flow responses to exercise in heart failure treated with angiotensin receptor neprilysin inhibitor

Published:2024-04 Issue: Volume:400 Page:131789
ISSN:0167-5273
Container-title:International Journal of Cardiology
language:en
Short-container-title:International Journal of Cardiology

Author:

Yamaguchi Natsumi,Hirata Yukina,Nishio Susumu,Takahashi Tomonori,Saijo Yoshihito,Kadota Muneyuki,Ise Takayuki,Yamaguchi Koji,Yagi Shusuke,Yamada Hirotsugu,Soeki Takeshi,Wakatsuki Tetsuzo,Sata Masataka,Kusunose Kenya

Funder

Japan Agency for Medical Research and Development

Vehicle Racing Commemorative Foundation

Japan Society for the Promotion of Science

Publisher

Elsevier BV

Reference29 articles.

1. Global burden of heart failure: a comprehensive and updated review of epidemiology;Savarese;Cardiovasc. Res.,2023

2. JCS/JHFS 2021 guideline focused update on diagnosis and treatment of acute and chronic heart failure;Tsutsui;Circ. J.,2021

3. Recent advances in the pharmacological therapy of chronic heart failure: evidence and guidelines;Tsutsui;Pharmacol. Ther.,2022

4. Angiotensin-neprilysin inhibition versus enalapril in heart failure;McMurray;N. Engl. J. Med.,2014

5. The angiotensin receptor neprilysin inhibitor LCZ696 in heart failure with preserved ejection fraction: a phase 2 double-blind randomised controlled trial;Solomon;Lancet.,2012

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exercise mean PAP to CO relationship: An insightful endpoint for testing therapeutic interventions in heart failure;International Journal of Cardiology;2024-05